Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joshua J DeClercq"'
Autor:
George J Leslie, Jianbin Wang, Max W Richardson, Beth S Haggarty, Kevin L Hua, Jennifer Duong, Anthony J Secreto, Andrea P O Jordon, Josephine Romano, Kritika E Kumar, Joshua J DeClercq, Philip D Gregory, Carl H June, Michael J Root, James L Riley, Michael C Holmes, James A Hoxie
Publikováno v:
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Externí odkaz:
https://doaj.org/article/b2848b8f422e4d1cb691aa0474392450
Autor:
Yen-Sheng Lin, Joshua J. DeClercq, Gregory D. Ayers, Ruby J. Gilmor, Garen Collett, Nitin B. Jain
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 160 (2023)
Background: Total hip arthroplasty (THA) has become a growing treatment procedure for debilitating hip pathologies. Patients experienced post-operative complications and revision surgeries according to large THA registries. To fully understand the sh
Externí odkaz:
https://doaj.org/article/0944275638d94358a453ac03016f2d1c
Autor:
Jianbin Wang, Josephine Romano, Beth S. Haggarty, Michael C. Holmes, James A. Hoxie, James L. Riley, Kevin Hua, Kritika E. Kumar, Andrea P. O. Jordon, George J. Leslie, Max W. Richardson, Philip D. Gregory, Anthony Secreto, Carl H. June, Jennifer Duong, Joshua J. DeClercq, Michael J. Root
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Autor:
Paula M. Cannon, Joshua J. DeClercq, Jianbin Wang, Philip D. Gregory, Colin M. Exline, Samuel B. Hayward, Richard T. Surosky, David A. Shivak, G. Nicholas Llewellyn, Michael C. Holmes, Patrick Li
Publikováno v:
Nature biotechnology
Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell populatio
Autor:
Jianbin Wang, Samuel B. Hayward, Gary Lee, Joshua J. DeClercq, David A. Shivak, Michael C. Holmes, Patrick Li
Publikováno v:
Molecular Therapy. 24:S54
Immunotherapy using gene-modified T cells for adoptive cell transfer is a rapidly expanding field that is currently being tested in early- and late-stage clinical studies, with recent successes seen in the treatment of hematologic malignancies using
Autor:
Joshua J. DeClercq, Jianbin Wang, Philip D. Gregory, David A. Shivak, Gary Lee, Samuel B. Hayward, Michael C. Holmes, Patrick Li
Publikováno v:
Nucleic Acids Research
The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectious disease is a rapidly growing field that has shown great promise in recent clinical trials. Nuclease-driven genome editing provides a method in which
Autor:
Carver AB; Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Zuckerman AD; Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA., DeClercq J; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Choi L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Chastain CA; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Nov 26; Vol. 7 (12), pp. ofaa569. Date of Electronic Publication: 2020 Nov 26 (Print Publication: 2020).
Autor:
Song A; Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee., DeClercq J; Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee., Ayers GD; Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee., Higgins LD; King Edward Memorial Hospital, Hamilton, Bermuda., Kuhn JE; Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee., Baumgarten KM; Orthopedic Institute of Sioux Falls, Sioux Falls, South Dakota., Matzkin E; Department of Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Jain NB; Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee.
Publikováno v:
The Journal of bone and joint surgery. American volume [J Bone Joint Surg Am] 2020 Jul 01; Vol. 102 (13), pp. 1142-1150.
Autor:
Zuckerman AD; Specialty Pharmacy Services, Vanderbilt University Medical Center,; Nashville, Tennessee, United States of America., Douglas A; Christy Houston Foundation Drug Information Center, Belmont University College of Pharmacy; Nashville, Tennessee, United States of America., Whelchel K; Specialty Pharmacy Services, Vanderbilt University Medical Center,; Nashville, Tennessee, United States of America., Choi L; Department of Biostatistics, Vanderbilt University Medical Center,; Nashville, Tennessee, United States of America., DeClercq J; Department of Biostatistics, Vanderbilt University Medical Center,; Nashville, Tennessee, United States of America., Chastain CA; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center,; Nashville, Tennessee, United States of America.
Publikováno v:
PloS one [PLoS One] 2019 Nov 21; Vol. 14 (11), pp. e0225434. Date of Electronic Publication: 2019 Nov 21 (Print Publication: 2019).
Autor:
Paolella D; Belmont University College of Pharmacy, Nashville, Tennessee., Cherry E; Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee., Jolly JA; Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee., DeClercq J; Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee., Choi L; Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee., Zuckerman A; Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2019 Nov; Vol. 25 (11), pp. 1282-1288.